Immunological effects and safe administration of alemtuzumab (MabCampath) in advanced B-cLL. (Q34785892)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180492%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Immunological effects and safe administration of alemtuzumab (MabCampath) in advanced B-cLL (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180492%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

2

Peter Hillmen

0 references

author name string

Ben Kennedy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180492%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

Peter Hillmen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180492%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180492%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180492%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

19 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180492%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

S49-55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12180492%20AND%20SRC:MED&resulttype=core&format=json

Infection and immunity in chronic lymphocytic leukemia.

12 November 2019

cites work

1 reference

12 December 2020

Effect of Campath-1H antibody on human hematopoietic progenitors in vitro

1 reference

12 December 2020

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

1 reference

12 December 2020

Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomas

1 reference

12 December 2020

Opportunistic infections in chronic lymphocytic leukemia

1 reference

12 December 2020

Prophylactic strategies to meet infectious complications in fludarabine-treated CLL.

1 reference

12 December 2020

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

12 December 2020

Repopulation of blood lymphocyte sub-populations in rheumatoid arthritis patients treated with the depleting humanized monoclonal antibody, CAMPATH-1H

1 reference

12 December 2020

Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab)

1 reference

12 December 2020

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

1 reference

12 December 2020

Infections in chronic lymphocytic leukemia: risk factors, and impact on survival, and treatment

1 reference

12 December 2020

Complications in the treatment of CLL with purine analogues

1 reference

12 December 2020

Infectious complications in chronic lymphocytic leukaemia

1 reference

12 December 2020

Monoclonal antibody therapy in lymphoid malignancies

1 reference

12 December 2020

Histoplasmosis in immunosuppressed patients

1 reference

12 December 2020

Cryptococcal prostatitis in a patient with chronic lymphocytic leukemia.

1 reference

12 December 2020

Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis

1 reference

12 December 2020

Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8).

1 reference

12 December 2020

Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis

1 reference

12 December 2020

CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study

1 reference

12 December 2020

A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens

1 reference

12 December 2020

Campath-1H monoclonal antibody therapy

1 reference

12 December 2020

Chronic indolent orofacial herpes simplex virus infection in chronic leukemia: a report of three cases

1 reference

12 December 2020

Infectious and immunosuppressive complications of purine analog therapy

1 reference

12 December 2020

Infections in patients with chronic lymphocytic leukemia treated with fludarabine

1 reference

12 December 2020

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis

1 reference

12 December 2020

Infectious complications of neoplastic disease

1 reference

12 December 2020

A phase II multicenter study of CAMPATH-1H antibody in previously treated patients with nonbulky non-Hodgkin's lymphoma

1 reference

12 December 2020

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma

1 reference

12 December 2020

The infectious complications of chronic lymphocytic leukemia.

1 reference

12 December 2020

Subcutaneous administration of CAMPATH-1H: clinical and biological outcomes

1 reference

12 December 2020

Chronic lymphocytic leukemia

1 reference

12 December 2020

Infections and serum IgG levels in patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Cryptococcosis in a cancer hospital.Clinical and pathological correlates in forty-six patients

1 reference

12 December 2020

CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study

1 reference

12 December 2020

Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia

1 reference

12 December 2020

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

1 reference

12 December 2020

Infusion reactions associated with the therapeutic use of monoclonal antibodies in the treatment of malignancy

1 reference

12 December 2020

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

12 December 2020

Fludarabine and cyclophosphamide with filgrastim support in patients with previously untreated indolent lymphoid malignancies

1 reference

12 December 2020